Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

Brain Research

Volumn 914, Issue 1-2, 2001, Pages 48-56

  Rockenstein, Edward ^a   Hansen, Lawrence A ^a,b   Mallory, Margaret ^a   Trojanowski, John Q ^c   Galasko, Douglas ^a   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Lewy body; Neurodegeneration; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; GAMMA SYNUCLEIN; MESSENGER RNA; SYNUCLEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; HUMAN; HUMAN TISSUE; LEWY BODY; NEOCORTEX; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROBE; SUBSTANTIA NIGRA; TEMPORAL CORTEX;

AGED; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BETA-SYNUCLEIN; BRAIN; GAMMA-SYNUCLEIN; GENE EXPRESSION; HUMANS; LEWY BODY DISEASE; LINEAR MODELS; NEOCORTEX; NERVE TISSUE PROTEINS; RNA, MESSENGER; STATISTICS; SUBSTANTIA NIGRA; SYNUCLEINS;

EID: 0035964758     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02772-X     Document Type: Article

References (55)

1. Peripheral nervous system-specific genes identified by subtractive cDNA cloning
2. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
3. Neuronal expression profile of alpha-synuclein in developing human cortex
4. Parkinson's disease associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologues
5. Neuropathological staging of Alzheimer-related changes
6. Persyn, a member of the synuclein family, influences neurofilament network integrity
7. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
8. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
9. The expression of α-, β- and γ-synucleins in olfactory mucosa from patients with and without neurodegenerative disorders
10. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions
11. A Drosophila model of Parkinson's disease
12. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein
13. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
14. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
15. Alpha-synuclein in Lewy body disease and Alzheimer's disease
16. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
17. Role of cytochrome c as a stimulator of α-synuclein aggregation in Lewy body disease
18. Mechanisms of α-synuclein and NAC fibrillogenesis
19. The cDNA cloning and ontogeny of mouse alpha-synuclein
20. Expression pattern of the non-Aβ component of Alzheimer's disease amyloid precursor protein (NACP/α-synuclein) during brain development
21. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity
22. The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system
23. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease
24. Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins
25. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing
26. Stimulation of breast cancer invasion and metastasis by synuclein gamma
27. Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury
28. Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine
29. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
30. The synuclein family
31. Mechanisms of synaptic pathology in Alzheimer's disease
32. The role of synaptic proteins in neurodegenerative disorders
33. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease
34. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
35. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the CDLB International Workshop
36. A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation
37. Alpha-synuclein shares physical and functional homology with 14-3-3 proteins
38. Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex
39. Mutation in the α-synuclein gene identified in families with Parkinson's disease
40. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease
41. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
42. Assignment of human α-synuclein (SNCA) and β-synuclein (SNCB) genes to chromosomes 4q21 and 5q35
43. α-Synuclein in Lewy bodies
44. Synoretin - A new protein belonging to the synuclein family
45. Human NACP/α-synuclein distribution in Lewy body disease
46. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders
47. Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human α-synuclein
48. Physical basis of cognitive alterations in Alzheimer disease: Synapse loss is the major correlate of cognitive impairment
49. Contribution of somal Lewy bodies to neuronal death
50. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigra neurons
51. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease
52. Neuropathology in mice expressing human alpha-synuclein
53. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
54. Alpha-synuclein fibrillogenesis is nucleation dependent. Implications for the pathogenesis of Parkinson's disease
55. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein